Naloxon OrPha, Injektionslösung
7680569520015
CH-56952
Injektionslösung
Associated product:
NALOXON OrPha sol inj 0.4 mg/ml 10 amp 1 ml
1 / 3
google
Article details
- Package size
- 10
- Selling units
- 10
- Measure
- Ampulle(n)
- Galenic form
- Injektionslösung
- Galenic group
- Injektion/Infusion
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.4 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.44 MG | Substance | WIZUS |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.54 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
OrPha Swiss GmbH
8700 Küsnacht ZH
Authorization information
- Swissmedic authorization number
- 56952
- Drug name
- Naloxon OrPha, Injektionslösung
- Galenic form
- LSPA
- ATC Code
- V03AB15
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 07/06/2004
- Authorization expiration date
- 31/12/9999
- IT Number
- 15.01.1.
- Domain
- Human medicine
Package details
- Description (FR)
- NALOXON OrPha sol inj 0.4 mg/ml 10 amp 1 ml
- Description (DE)
- NALOXON OrPha Inj Lös 0.4 mg/ml 10 Amp 1 ml
- Market launch
- 07/06/2004
- Narcotic (BTM)
- No
Other package sizes (1)
NALOXON NEONATAL Orpha sol inj 10 amp 2 ml
10 AMP
GTIN: 7680569520039